Header cover image

Taiwanese (TAIEX) Biotech Industry Analysis

UpdatedMar 26, 2024
DataAggregated Company Financials
Companies59
  • 7D1.0%
  • 3M-5.0%
  • 1Y-21.7%
  • YTDn/a

Last week, the Biotech industry hasn't moved much but Polaris Group is up 11% in that time. As for the longer term, the industry has declined 22% in the last year. Looking forward, earnings are forecast to grow by 108% annually.

Industry Valuation and Performance

Has the Taiwanese Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 26 Mar 2024NT$436.3bNT$20.9b-NT$10,146,524,000.0052.8x-43x20.9x
Thu, 22 Feb 2024NT$449.6bNT$19.9b-NT$9,857,794,000.0039.7x-45.6x22.6x
Sat, 20 Jan 2024NT$449.8bNT$19.8b-NT$9,748,146,000.0039.9x-46.1x22.8x
Mon, 18 Dec 2023NT$474.3bNT$19.9b-NT$9,737,975,000.0042.5x-48.7x23.9x
Wed, 15 Nov 2023NT$465.9bNT$19.0b-NT$10,324,208,000.0047x-45.1x24.5x
Fri, 13 Oct 2023NT$467.2bNT$18.3b-NT$10,774,226,000.0046.1x-43.4x25.5x
Sun, 10 Sep 2023NT$487.9bNT$18.3b-NT$10,596,353,000.0042.6x-46x26.6x
Tue, 08 Aug 2023NT$467.8bNT$18.6b-NT$10,798,870,000.0051.5x-43.3x25.2x
Thu, 06 Jul 2023NT$486.0bNT$18.7b-NT$10,709,428,000.0044x-45.4x26x
Sat, 03 Jun 2023NT$493.7bNT$18.8b-NT$10,346,471,000.0043.4x-47.7x26.3x
Mon, 01 May 2023NT$515.7bNT$18.5b-NT$9,925,325,000.0044.1x-52x27.9x
Wed, 29 Mar 2023NT$500.8bNT$20.5b-NT$9,016,573,000.0037.6x-55.5x24.5x
Fri, 24 Feb 2023NT$527.8bNT$21.8b-NT$7,840,926,000.0038x-67.3x24.2x
Sun, 22 Jan 2023NT$494.2bNT$21.8b-NT$7,778,690,000.0036.2x-63.5x22.7x
Tue, 20 Dec 2022NT$510.1bNT$21.8b-NT$7,522,211,000.0037.4x-67.8x23.4x
Thu, 17 Nov 2022NT$504.4bNT$23.1b-NT$6,733,048,000.0032.7x-74.9x21.8x
Sat, 15 Oct 2022NT$475.0bNT$23.1b-NT$6,633,590,000.0034.7x-71.6x20.6x
Mon, 12 Sep 2022NT$630.8bNT$23.1b-NT$6,633,590,000.0044.6x-95.1x27.3x
Wed, 10 Aug 2022NT$558.6bNT$22.6b-NT$5,710,103,000.0032.2x-97.8x24.7x
Fri, 08 Jul 2022NT$510.4bNT$22.5b-NT$5,642,821,000.0030.4x-90.5x22.6x
Sun, 05 Jun 2022NT$502.1bNT$22.5b-NT$5,642,821,000.0032.1x-89x22.3x
Tue, 03 May 2022NT$529.2bNT$21.6b-NT$5,790,297,000.0045.2x-91.4x24.6x
Thu, 31 Mar 2022NT$528.2bNT$19.6b-NT$4,949,407,000.0029.2x-106.7x27x
Sat, 26 Feb 2022NT$456.8bNT$17.9b-NT$5,564,340,000.0024.9x-82.1x25.5x
Mon, 24 Jan 2022NT$428.1bNT$17.9b-NT$5,532,702,000.0024.3x-77.4x23.9x
Wed, 22 Dec 2021NT$446.4bNT$17.9b-NT$5,579,296,000.0026.9x-80x24.9x
Fri, 19 Nov 2021NT$368.1bNT$18.2b-NT$6,360,614,000.0022.5x-57.9x20.2x
Sun, 17 Oct 2021NT$345.2bNT$15.4b-NT$7,624,179,000.0019.9x-45.3x22.4x
Tue, 14 Sep 2021NT$384.2bNT$15.4b-NT$7,624,179,000.0021.7x-50.4x25x
Thu, 12 Aug 2021NT$394.4bNT$15.4b-NT$7,624,179,000.0020.5x-51.7x25.6x
Mon, 07 Jun 2021NT$405.6bNT$13.7b-NT$8,453,670,500.0025.9x-48x29.5x
Price to Earnings Ratio

-48.4x


Total Market Cap: NT$409.4bTotal Earnings: -NT$8,453,670,500.00Total Revenue: NT$13.7bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Biotech Industry Price to Earnings3Y Average -63x202220232024
Current Industry PE
  • Investors are pessimistic on the Taiwanese Biotechnology industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 24.8x is higher than the industry's current PS ratio of 20.7x.
Past Earnings Growth
  • The earnings for companies in the Biotechnology industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 15% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Comparison

How does Taiwanese Biotech compare with similar industries?

TW Market1.52%
Healthcare1.71%
Biotech1.01%
Biotech1.01%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6550 Polaris GroupNT$68.5011.6%
+NT$5.3b
-30.0%PS14542.3x
6976 AcepodiaNT$28.8510.7%
+NT$1.6b
n/aPE-11.6x
4728 Sunmax BiotechnologyNT$224.506.9%
+NT$789.7m
59.8%PE19.5x
4157 TaiGen Biopharmaceuticals HoldingsNT$15.355.9%
+NT$610.2m
1.0%PE80.6x
6657 Energenesis BiomedicalLTDNT$58.306.8%
+NT$281.3m
-8.6%PS619.2x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

6875

NT$92.00

Pharmosa Biopharm

7D

-11.1%

1Y

16.0%

6976

NT$28.85

Acepodia

7D

10.7%

1Y

n/a

4132

NT$31.90

Golden Biotechnology

7D

-15.9%

1Y

-34.8%

4147

NT$88.10

TaiMed Biologics

7D

-3.3%

1Y

-5.0%

6492

NT$43.05

Senhwa Biosciences

7D

3.4%

1Y

-21.7%

4157

NT$15.35

TaiGen Biopharmaceuticals Holdings

7D

5.9%

1Y

1.0%

4728

NT$224.50

Sunmax Biotechnology

7D

6.9%

1Y

59.8%

6547

NT$52.00

Medigen Vaccine Biologics

7D

-2.4%

1Y

-8.5%

6541

NT$48.10

Tanvex BioPharma

7D

-6.1%

1Y

-44.7%

6617

NT$187.50

Gongwin Biopharm Holdings

7D

1.1%

1Y

-39.4%

6446

NT$318.00

PharmaEssentia

7D

-4.4%

1Y

-27.6%

6657

NT$58.30

Energenesis BiomedicalLTD

7D

6.8%

1Y

-8.6%

6696

NT$97.70

Lin BioScience

7D

-3.3%

1Y

-46.8%

6539

NT$43.00

DV Biomed

7D

-10.4%

1Y

-17.0%

6808

NT$34.55

3D Global Biotech

7D

11.5%

1Y

14.0%

6550

NT$68.50

Polaris Group

7D

11.6%

1Y

-30.0%